Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | TSHR | P16473 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4458916 | 0.80 | CA2 (0.34) | CA2ALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL5644733 | 0.79 | CA2 (0.36) | CA2ALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL3360175 | 0.78 | CA2 (0.42) | CA2ALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL23440236 | 0.78 | CA2 (0.33) | CA2ALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL5645403 | 0.77 | CA2 (0.41) | CA2ALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL4596738 | 0.77 | CA2 (0.32) | CA2ALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL5643653 | 0.75 | CA2 (0.39) | CA2ALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL9053319 | 0.74 | CA2 (0.30) | CA2 | |
| SCHEMBL5648901 | 0.73 | CA2 (0.38) | CA2ALDH1A1TSHRTDP1CYP3A4 | |
| SCHEMBL5646317 | 0.73 | CA2 (0.38) | CA2ALDH1A1TSHRTDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 359 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-7196926-A | — | — | None | — | — | JP | disclosed |
| EP-4703405-A1 | CRYSTALLINE POLYOXYALKYLENE-BASED POLYMER AND CURABLE COMPOSITION COMPRISING SAME | Kaneka Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703367-A1 | RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT | Kaneka Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703406-A1 | HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT | Kaneka Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| US-20260049203-A1 | CURABLE COMPOSITION | KANEKA NORTH AMERICA LLC (US) | 2026-02-19 | — | — | US | disclosed |
| US-20260049176-A1 | HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT | KANEKA CORPORATION (JP) | 2026-02-19 | — | — | US | disclosed |
| US-20260049182-A1 | RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT | KANEKA CORPORATION (JP) | 2026-02-19 | — | — | US | disclosed |
| EP-4692247-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260022211-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2026-01-22 | — | — | US | disclosed |
| EP-4682204-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2026-01-21 | — | — | EP | disclosed |
| EP-1553150-A1 | SEALING MATERIAL USED FOR TRANSPARENT MATERIAL HAVING PHOTOCATALYST LAYER | Kaneka Corporation (JP) | 2005-07-13 | — | — | EP | disclosed |
| EP-1550700-A1 | CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2005-07-06 | — | — | EP | disclosed |
| EP-1550701-A1 | ONE-PART CURABLE COMPOSITION | KANEKA CORPORATION (JP) | 2005-07-06 | — | — | EP | disclosed |
| EP-1533341-A1 | CURABLE COMPOSITION AND SEALING METHOD FOR CERAMIC SIDING BOARDS | KANEKA CORPORATION (JP) | 2005-05-25 | — | — | EP | disclosed |
| US-6576733-B1 | End group comprising hydrolyzable silicon; divalent tin carboxylate, and amine; narrow molecular weight distribution; elastic sealants | KANEGAFUCHI CHEMICAL INDUSTRY CO., LTD. (JP) | 2003-06-10 | — | — | US | disclosed |
| EP-0473793-B1 | CURABLE COMPOSITION | KANEGAFUCHI CHEMICAL IND (JP) | 1996-06-12 | — | — | EP | disclosed |
| JP-H07196926-A | CURABLE COMPOSITION | ASAHI GLASS CO LTD | 1995-08-01 | — | — | JP | disclosed |
| EP-0473793-A1 | CURABLE COMPOSITION | Kanegafuchi Chemical Industry Co., Ltd. (JP) | 1992-03-11 | — | — | EP | disclosed |
| US-4053941-A | 1,1-PHENYLXYLYLETHANE | MATSUSHITA ELECTRIC INDUSTRIAL CO., LTD. (JA) | 1977-10-11 | — | — | US | disclosed |
| US-3983046-A | Functional fluid compositions containing epoxy additives | MCDONNELL DOUGLAS CORPORATION (US) | 1976-09-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260049176-A1 | HYDROLYZABLE SILYL GROUP-CONTAINING POLYOXYALKYLENE POLYMER, CURABLE COMPOSITION, AND CURED PRODUCT | PSMA1, LIPA, SGMS1 | CA2 3098/4885ALDH1A1 125/4885TSHR 4563/4885 |
| US-20260049182-A1 | RUTHENIUM COMPLEX, METHOD FOR PRODUCING SILYL GROUP-CONTAINING COMPOUND, SILYL GROUP-CONTAINING POLYMER MIXTURE, CURABLE COMPOSITION, AND CURED PRODUCT | ILK, CROCC, SEM1 | CA2 1002/4885ALDH1A1 511/4885TSHR 4869/4885 |
| US-20260049203-A1 | CURABLE COMPOSITION | FLNA, FLNB, FSCN1 | CA2 2881/4885ALDH1A1 3439/4885TSHR 1898/4885 |
| US-20260022211-A1 | CURABLE COMPOSITION | H1-4, H1-0, H1-2 | CA2 1656/4885ALDH1A1 2939/4885TSHR 2520/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.